Federal Health Grants

The National Heart, Lung, and Blood Institute (NHLBI) intends to publish a Request for Applications (RFA) seeking applications for a multisite clinical trial that will test a screening approach to identify coronary atherosclerosis and test interventions to reduce the progression of coronary atherosclerosis. There will be only one award for this RFA. The planned RFA will utilize the UG3/UH3 activity code with details provided below. The planned RFA will support a Clinical Coordinating Center (CCC) and will run in parallel with a companion RFA for a collaborating Data Coordinating Center (DCC) application.This RFA will accept only an application that is part of a collaborative pair of applications. The pair must include one application to the CCC UG3/UH3 Notice of Funding Opportunity (NOFO) plus one application to the companion DCC U24 NOFO.Both a CCC application and a collaborating DCC application must be submitted on the same due date for consideration by NHLBI. CCC (UG3/UH3) applications submitted without a collaborative DCC (U24) application will be deemed incomplete and will not proceed to review. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The planned RFAs are expected to be published in Summer 2024 with an expected application due date in Fall 2024.

This funding opportunity provides financial support to state, local, and territorial public health departments to strengthen their ability to detect, respond to, and prevent emerging infectious diseases.

Reissue of RFA-MH-20-401.This Funding Opportunity Announcement (FOA) supports pilot work for subsequent studies testing the effectiveness of strategies to deliver evidence-based mental health services, treatment interventions, and/or preventive interventions (EBPs) in low-resource mental health specialty and non-specialty settings within the United States. The FOA targets settings where EBPs are not currently delivered or delivered with fidelity, such that there are disparities in mental health and related functional outcomes (e.g., employment, educational attainment, stable housing, integration in the community, treatment of comorbid substance use disorders, etc.) for the population(s) served. Implementation strategies should identify and use innovative approaches to remediate barriers to provision, receipt, and/or benefit from EBPs and generate new information about factors integral to achieving equity in mental health outcomes for underserved populations.

This funding opportunity supports organizations in rural areas to improve healthcare access and services tailored to local needs, focusing on collaboration among multiple healthcare providers.

This grant provides funding for large-scale, collaborative research projects that explore complex questions related to aging, requiring a multidisciplinary team and integration of various components across institutions.

This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Phased Innovation Award (R61/R33) mechanism to provide up to 2 years of R61 support for initial developmental activities and up to 3 years of R33 support for expanded activities. Through this award, investigators will develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.

This grant provides funding for academic training programs to increase the number of qualified rehabilitation professionals who assist individuals with mental health disorders and other disabilities.

This grant provides financial support and mentorship for outstanding graduate students in the U.S. who are pursuing a PhD in cancer research, helping them transition to postdoctoral training and independent research careers.

This funding opportunity supports researchers exploring the biological and genetic factors contributing to cancer health disparities among racial and ethnic groups, aiming to generate insights for future studies.

This funding opportunity supports U.S. higher education institutions in conducting interdisciplinary research that integrates human behavior into epidemiological models to improve public health interventions during pandemics.

This funding opportunity is designed for U.S.-based small businesses to create engaging digital educational tools that teach pre-college students and teachers about biomedical sciences through interactive learning.

Black/African Americans have been disproportionately affected by HIV since the early days of the epidemic and that disparity has deepened over time. Although they represent only 12% of the population, Black/African Americans account for approximately 43% of new HIV diagnosis. This disparity is further exacerbated by the critical shortage of primary care providers trained to provide counseling, HIV testing, prescribe PrEP and HIV care and treatment. This is especially true for the number of providers working in communities most at-risk for HIV. The purpose of the Building Workforce Capacity through Pathways in HIV Residency Training Program (Pathways Program) is to train internal and family medicine residents in HIV treatment and care management with the goal of increasing the number and diversity of HIV providers.

This funding opportunity provides financial support and mentorship for researchers with doctoral degrees to develop their careers in health services research, focusing on improving healthcare quality and equity in the United States.

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) that were developed for the treatment of type 2 diabetes (T2D) have significant protective effects for cardiac and renal diseases for people with and without diabetes. However, SGLT2i are not currently approved for individuals with type 1 diabetes (T1D) and there is an increased risk of diabetic ketoacidosis (DKA) for this population. Despite this concern, these drugs are increasingly being prescribed off-label for people with T1D. Continuous ketone monitoring (CKM) is a rapidly evolving technology that could be utilized clinically to prevent DKA by an early warning of elevations in ketone levels.The purpose of this NOFO is to solicit applications for studies that will develop and test risk mitigation strategies that involve the clinical integration of CKM for the safe use of SGLT2i for people living with T1D so that they may benefit from the cardiac and renal protection and glucose-lowering effects of this drug class. The NOFO will support short-term, clinical trials to gain and disseminate knowledge on safety and glucose control with CKM and SGLT2i use.Possible topics include testing optimal insulin delivery in open and closed loop systems or multiple daily injections and developing clinical protocols to control or ameliorate elevated ketone levels in individuals with T1D who are receiving adjunct therapy with SGLT2i.

This funding opportunity supports innovative research on how substance use disorders affect HIV infection and latency in the brain, encouraging collaboration among researchers in HIV, neuroscience, and addiction.

This grant provides funding for research on how climate change affects cancer risks, prevention, treatment, and survivorship, particularly focusing on vulnerable populations and health disparities.

This funding opportunity provides financial support to organizations that will assist Botswana's Ministry of Health in implementing national HIV policies and improving care and mental health services for children and adolescents living with HIV.

This funding opportunity supports collaborative projects between academic institutions and industry to develop innovative bioengineering solutions that address significant biomedical challenges and improve medical practices.

The Agency for Healthcare Research and Quality's (AHRQ) mission is to produce evidence to make health care safer, of higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used. AHRQ's Center for Quality Improvement and Patient Safety (CQuIPS) works to ensure patient safety in multiple settings with recent efforts to increase the development of processes including measures, metrics, tools and practices to increase patient safety in the ambulatory care setting and in long-term care facilities.

This funding opportunity supports youth-led conferences and workshops across the Pacific region, aimed at empowering emerging leaders aged 25 to 40 to collaboratively tackle critical regional challenges in areas such as security, food supply, digital media, and public health.